Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
BP sells $1.5B stakes in US midstream assets to focus on profitability and meet divestment targets.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
BP sells $1.5B stakes in US midstream assets to focus on profitability and meet divestment targets.